4-41745967-C-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_003924.4(PHOX2B):​c.785G>T​(p.Gly262Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,342,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G262D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

PHOX2B
NM_003924.4 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts P:1U:5

Conservation

PhyloP100: 1.07

Publications

1 publications found
Variant links:
Genes affected
PHOX2B (HGNC:9143): (paired like homeobox 2B) The DNA-associated protein encoded by this gene is a member of the paired family of homeobox proteins localized to the nucleus. The protein functions as a transcription factor involved in the development of several major noradrenergic neuron populations and the determination of neurotransmitter phenotype. The gene product is linked to enhancement of second messenger-mediated activation of the dopamine beta-hydroylase, c-fos promoters and several enhancers, including cyclic amp-response element and serum-response element. Expansion of a 20 amino acid polyalanine tract in this protein by 5-13 aa has been associated with congenital central hypoventilation syndrome. [provided by RefSeq, Jul 2016]
PHOX2B Gene-Disease associations (from GenCC):
  • central hypoventilation syndrome, congenital, 1, with or without Hirschsprung disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • Haddad syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • neuroblastoma, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P
  • congenital central hypoventilation syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20323712).
BS2
High AC in GnomAdExome4 at 14 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHOX2BNM_003924.4 linkc.785G>T p.Gly262Val missense_variant Exon 3 of 3 ENST00000226382.4 NP_003915.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHOX2BENST00000226382.4 linkc.785G>T p.Gly262Val missense_variant Exon 3 of 3 1 NM_003924.4 ENSP00000226382.2
PHOX2BENST00000510424.2 linkn.*66G>T downstream_gene_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00000669
AC:
1
AN:
149510
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000291
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000323
AC:
3
AN:
92736
AF XY:
0.0000186
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000407
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000218
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000117
AC:
14
AN:
1193402
Hom.:
0
Cov.:
31
AF XY:
0.00000862
AC XY:
5
AN XY:
580288
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25544
American (AMR)
AF:
0.00
AC:
0
AN:
16506
Ashkenazi Jewish (ASJ)
AF:
0.000643
AC:
12
AN:
18676
East Asian (EAS)
AF:
0.00
AC:
0
AN:
29796
South Asian (SAS)
AF:
0.00
AC:
0
AN:
36094
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36106
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3812
European-Non Finnish (NFE)
AF:
0.00000102
AC:
1
AN:
979150
Other (OTH)
AF:
0.0000210
AC:
1
AN:
47718
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000669
AC:
1
AN:
149510
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
72864
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41186
American (AMR)
AF:
0.00
AC:
0
AN:
15054
Ashkenazi Jewish (ASJ)
AF:
0.000291
AC:
1
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9688
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66892
Other (OTH)
AF:
0.00
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000195
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital central hypoventilation Pathogenic:1Uncertain:1
Aug 26, 2021
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Sep 25, 2019
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Hereditary cancer-predisposing syndrome Uncertain:2
Mar 12, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.G262V variant (also known as c.785G>T), located in coding exon 3 of the PHOX2B gene, results from a G to T substitution at nucleotide position 785. The glycine at codon 262 is replaced by valine, an amino acid with dissimilar properties. This alteration has been identified in trans with a polyalanine repeat expansion mutation (PARM) with 24 alanines in a 3 year old diagnosed with congenital central hypoventilation syndrome (Sivan Y et al. Am J Med Genet A, 2019 03;179:503-506). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. -

Sep 14, 2021
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Haddad syndrome Uncertain:1
Oct 23, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 262 of the PHOX2B protein (p.Gly262Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with congenital central hypoventilation syndrome (PMID: 30672101). ClinVar contains an entry for this variant (Variation ID: 467746). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Aug 04, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Identified in the heterozygous or homozygous state in individuals with CCHS, both of whom had multiple unaffected relatives also heterozygous for the variant (Sivan et al., 2023); This variant is associated with the following publications: (PMID: 30672101, 37373665, 33958749) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Uncertain
0.080
D
BayesDel_noAF
Benign
-0.12
CADD
Benign
21
DANN
Benign
0.95
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.76
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.51
T
M_CAP
Pathogenic
0.82
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.39
T
MutationAssessor
Benign
0.0
N
PhyloP100
1.1
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.040
N
REVEL
Benign
0.27
Sift
Benign
0.047
D
Sift4G
Benign
0.39
T
Polyphen
0.0
B
Vest4
0.36
MutPred
0.41
Gain of helix (P = 0.0082);
MVP
0.67
MPC
1.4
ClinPred
0.032
T
GERP RS
2.1
Varity_R
0.10
gMVP
0.63
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768420488; hg19: chr4-41747984; API